Hypersensitivity reactions to proton pump inhibitors in childhood.


Journal

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
ISSN: 1399-3038
Titre abrégé: Pediatr Allergy Immunol
Pays: England
ID NLM: 9106718

Informations de publication

Date de publication:
11 2020
Historique:
received: 08 08 2020
accepted: 12 08 2020
entrez: 25 11 2020
pubmed: 26 11 2020
medline: 19 8 2021
Statut: ppublish

Résumé

Hypersensitivity reactions (HRs) to proton pump inhibitors (PPIs) are mainly described in adults. Anyway, increased use of PPIs in childhood has been observed in recent years. In the literature, only case reports are published on children. Most of the PPI HRs are IgE-mediated. Skin test concentrations and allergy workup protocols used for adults are also applied in children. This study underlies that multicentric pediatric studies focusing on PPI reactions in children are needed.

Identifiants

pubmed: 33236429
doi: 10.1111/pai.13345
doi:

Substances chimiques

Proton Pump Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-32

Informations de copyright

© 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Références

Kepil Ozdemir S, Bavbek S. Hypersensitivity reactions to proton-pump inhibitors: Clinical presentation, diagnosis, and management. Allergy Asthma Proc. 2020;41:37-44.
Natsch S, Vinks MH, Voogt AK, et al. Anaphylactic reactions to proton-pump inhibitors. Ann Pharmacother. 2000;34:474-476.
Tourillon C, Mahe J, Baron A, et al. Immediate-type hypersensitivity cross-reactions to proton pump inhibitors: a descriptive study of data from the French National Pharmacovigilance database. Int Arch Allergy Immunol. 2019;178:159-166.
Reyes Balaguer J, Campos Andreu A, Hernández Fernández de Rojas D. Anaphylaxis to proton pump inhibitors. Med Clin (Barc). 2007;128:799.
Tayman C, Mete E, Catal F, Tonbul A. Hypersensitivity reaction to omeprazole in a child. J Investig Allergol Clin Immunol. 2009;19:64-79.
Baldassarre E, Mendoza Sagaon M, Ferrarini A, et al. Severe systemic adverse reaction to proton pump inhibitors in an infant. Pediatr Pulmonol. 2007;42:563-564.
Bonadonna P, Lombardo C, Bortolami O, et al. Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test. J Allergy Clin Immunol. 2012;130:547-549.
Otani IM, Banerji A. Immediate and delayed hypersensitivity reactions to proton pump inhibitors: evaluation and management. Curr Allergy Asthma Rep. 2016;16:17.
Laguna JJ, Bogas G, Salas M, Mayorga C. The basophil activation test can be of value for diagnosing immediate allergic reactions
to omeprazole. J Allergy Clin Immunol Pract. 2018;6:1628-1636.e2.
Confino-Cohen R, Goldberg A. Anaphylaxis to omeprazole: diagnosis and desensitization protocol. Ann Allergy Asthma Immunol. 2006;96:33-36.

Auteurs

Francesca Mori (F)

Allergy Unit, Department of Pediatrics, Meyer Children's University Hospital, Florence, Italy.

Fabrizio Franceschini (F)

UOC Pediatria, Azienda Ospedaliero-Universitaria "Ospedali Riuniti", Ancona, Italy.

Francesca Saretta (F)

SC Pediatria, Ospedale Latisana-Palmanova, Dipartimento Materno-Infantile Azienda Sanitaria, Universitaria Friuli Centrale, Italy.

Annamaria Bianchi (A)

Pediatria, Ospedale San Camillo, Roma, Italy.

Paolo Bottau (P)

Pediatria e Neonatologia, Ospedale di Imola, Imola, Italy.

Silvia Caimmi (S)

Clinica Pediatrica Policlinico San Matteo, University di Pavia, Pavia, Italy.

Giuseppe Crisafulli (G)

UO Allergologia, Dipartimento di Pediatria, Università di Messina, Messina, Italy.

Lucia Liotti (L)

Pediatria, Ospedale Principi di Piemonte, Senigallia, Italy.

Claudia Paglialunga (C)

UOC di Pediatria, Azienda Ospedaliera-Universitaria "Consorziale-Policlinico", Ospedale Pediatrico Giovanni XXIII, Bari, Italy.

Carlo Caffarelli (C)

Clinica Pediatrica, Dipartimento Medicina e Chirurgia, Università di Parma, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH